undefined

Steven A. Greenberg

Dr. Steven A. Greenberg from Harvard Medical School analyzed publicly available gene expression data from various cancer types, including lung cancer, melanoma, and colorectal cancer to identify immune-related proteins that could complement existing therapies, such as PD-1 inhibitors.

Best podcasts with Steven A. Greenberg

Ranked by the Snipd community
undefined
4 snips
Jan 28, 2025 • 7min

A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1

Dr. Steven A. Greenberg from Harvard Medical School, a leading researcher in cancer immunotherapy, discusses a groundbreaking discovery on the relationship between immune proteins KLRG1 and PD-1. He highlights how this connection could explain the varying effectiveness of current treatments and suggests new strategies to combine therapies for improved outcomes. The conversation explores the immune system's battle against cancer and how targeting both KLRG1 and PD-1 might revolutionize treatment options for patients facing challenging cancers.